Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
Escherichia coli Nissle is a probiotic that decreases visceral pain associated with irritable bowel syndrome. Here, the authors show that the microbe produces an analgesic lipopeptide, structurally related to GABA, that can cross the gut epithelial barrier and inhibits visceral hypersensitivity in m...
Guardado en:
Autores principales: | Teresa Pérez-Berezo, Julien Pujo, Patricia Martin, Pauline Le Faouder, Jean-Marie Galano, Alexandre Guy, Claude Knauf, Jean Claude Tabet, Sophie Tronnet, Frederick Barreau, Maud Heuillet, Gilles Dietrich, Justine Bertrand-Michel, Thierry Durand, Eric Oswald, Nicolas Cenac |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14fbaec632884e6fbafc02bc5cea62fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The carbon storage regulator (Csr) system exerts a nutrient-specific control over central metabolism in Escherichia coli strain Nissle 1917.
por: Olga Revelles, et al.
Publicado: (2013) -
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Pichet Praveschotinunt, et al.
Publicado: (2019) -
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
por: Sya N Ukena, et al.
Publicado: (2007) -
E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
por: Theodore A. Chavkin, et al.
Publicado: (2021) -
Anabaenolysins, novel cytolytic lipopeptides from benthic Anabaena cyanobacteria.
por: Jouni Jokela, et al.
Publicado: (2012)